European Archives - Page 137 of 1585 - European Medical Journal

Review of the the International Society of Gynaecological Endocrinology (ISGE) 2026 Congress

THIS YEAR, Rome, Italy, welcomed the International Society of Gynecological Endocrinology (ISGE) Congress 2026, marking a…

EMJ Reproductive Health 12 [Supplement 1] 2026

We are delighted to announce the release of the latest EMJ Reproductive Health Supplement journal! Inside, you will find a diverse array…

The Personalised Approach for MHT Selection During Menopausal Transition

The choice of menopausal hormone therapy (MHT) is traditionally guided by the need to alleviate climacteric symptoms by correcting…

Insomnia Disorder During Menopausal Transition

Experts discuss insomnia disorder during menopause, health risks, diagnostic gaps, and emerging treatments including orexin receptor…

Christopher Wolfgang

Onc Now: Innovation and Insight in Pancreatic Cancer

In this episode of Onc Now, Christopher Wolfgang shares insights into the evolving landscape of pancreatic cancer research and treatment…

Cardiovascular Outcomes of MHT Initiated in Women Aged ≥60 Years or ≥10 Years Post-menopause

Menopause hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms and other manifestations of the…

Early Menopause and Brain Health

The symposium ‘The Troubled Journey of the Menopausal Transition’ brought together leading experts to explore the complex clinical and…

Endometriosis Care: One Size Doesn’t Fit a Lifetime

A session titled ‘Endometriosis and Adenomyosis’ at the International Society for Gynecological Endocrinology (ISGE) Congress 2026…

Phenotypic and Functional Characterisation of Primary Endometriotic Stromal Cells

Endometriosis is a chronic gynaecological disorder affecting approximately 190 million women of reproductive age. It is characterised by…

Frequency of Genitourinary Syndrome of Menopause Symptoms in Chinese-Speaking Sex Workers

Sydney Sexual Health Centre (SSHC) is a publicly funded sexual health clinic for clients from key priority populations who are seen free…